BlueWave Marine Ingredients, maker of ultra-low molecular weight fish peptides for human and animal nutrition, has sold a majority stake of its shares to 3D Corporate Solutions L.L.C., a US-headquartered nutrition business.
Scott Walker, CEO of 3D, notes “BlueWave is a key acquisition for us as we move forward. It jump starts our marine platform, allows us geographic presence outside North America, and BlueWave’s Peruvian facility links well to our growing Human/Functional Nutrition business.” Walker went on to detail that BlueWave represents strong synergies with some other 3D strategic initiatives, including 3D strategic partner JT Naturals (Joplin, Missouri, USA) in the marketing of BlueWave Oils and Refined Peptides into the booming nutraceutical space.
Michael Mussell, CEO of BlueWave, enthusiastically supports 3D’s new ownership. “During the last 4-5 years, we expanded our platform with strategic partners and four new factories utilizing a proprietary/patented process technology. It is an ideal time for a strong marketing partner and 3D is a perfect fit.”
3D Corporate Solutions, headquartered in Monett, Missouri, USA, is employee-owned (ESOP) and is a four consecutive-time honoree on the Inc. 5000 list of the fastest-growing, privately held companies in America. 3D produces and sources ingredients in the nutrition industries for pets, feed, and food. 3D also provides warehousing and logistics services. The company participates in numerous industry associations and local community events.
BlueWave Marine Ingredients operates four factories (Peru, Ecuador, Spain, Morocco), utilizing sustainable marine sources to produce low molecular weight peptides noted for their exceptional digestibility, purity, and bioavailability.
New shelter data casts doubt on whether the pet population and pet ownership are truly growing.
While the pandemic caused unprecedented suffering worldwide in 2020, the disruptions to dogs, cats and other pets adoption numbers may normalize in 2021.